From the National Institutes of Health’s National Institute of Diabetes and Digestive and Kidney Diseases:
Advanced Clinical Trials to test Artificial Pancreas Device Systems in Type 1 Diabetes
NIH/NIDDK is seeking researchers to conduct advanced clinical trials to test the outpatient clinical safety and efficacy of artificial pancreas systems for type 1 diabetes. Artificial pancreas systems are designed to improve glycemic control, reduce acute complications and improve quality of life.
A letter of intent is due by February 9th, 2016 and applications are due by March 9th, 2016.
Find more information here.